Companies / RedHill Biopharma Ltd.

RedHill Biopharma Ltd.

Nasdaq: RDHLForeign · IFRSCIK 1553846TEL AVIV

Financials · FY2024

Revenue$8.04M
Net income$-8.27M
Total debt
Cash$2.87M
Diluted EPS$0.00
Shares outstanding50.92B

Ownership

50.92B shares outstanding
0.00%Institutions
Ownership
Institutions<0.01%515,228
Public float100.00%50,922,745,772

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Ben-Asher DrorCEOChief Executive Officer · Director
Frish AdiChief Corp & BD Officer
Goldberg Guy JoelChief Business Officer
Ingber RaziChief Financial Officer
Mamluk RoniDirector
Raday GileadChief Operating Officer
Reed KennethDirector
Scruggs Rick DChief Commercial Officer · Director
Tsimchi OferDirector

Institutional holders 19

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RDHLADREquity757468301BBG003RY91S7